Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients-Reference-Cited by-同舟云学术

Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients

Published:2012-05-21 Issue:12 Volume:28 Page:969-973
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Genazzani Alessandro D.,Prati Alessia,Santagni Susanna,Ricchieri Federica,Chierchia Elisa,Rattighieri Erica,Campedelli Annalisa,Simoncini Tommaso,Artini Paolo G.

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2012.685205

Reference30 articles.

1. POLYCYSTIC OVARY SYNDROME

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

3. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

4. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myo-inositol rescued insulin resistance and dyslipidemia in db/db mice;Journal of Applied Biomedicine;2024-06-24

2. Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients;Gynecological Endocrinology;2024-04-15

3. Advances in the study of the correlation between insulin resistance and infertility;Frontiers in Endocrinology;2024-01-26

4. Myo-inositol versus metformin effects on clinical features, endocrine and metabolic profiles in infertile women with polycystic ovary syndrome: A randomized controlled trial;Asian Pacific Journal of Reproduction;2023-12

5. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome;Journal of Endocrinological Investigation;2023-10-31